Candel Therapeutics (CADL) FCF Margin (2020 - 2022)
Candel Therapeutics' (CADL) quarterly FCF Margin came in at 21590.32% in Q4 2022, up 7410968.0% year-on-year from N/an in Q4 2021, and up 24.28% quarter-over-quarter from 28512.9% in Q3 2022.
Candel Therapeutics (CADL) FCF Margin (2020 - 2022) Analysis & Trends
Candel Therapeutics has disclosed FCF Margin across 3 years of filings, most recently posting 21590.32% for Q4 2022.
- FCF Margin for Q4 2022 came in at 21590.32%, up 7410968.0% year-over-year; the trailing twelve-month figure through Dec 2022 was 25393.55% (down 109759.0% YoY), and the FY2022 annual result was 25190.4%, down 113740.0% from the prior year.
- FCF Margin came in at 21590.32% for Q4 2022 at Candel Therapeutics, up from 28512.9% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 4119.35% in Q3 2020 to a low of 95700.0% in Q4 2021.
- The 3-year median for FCF Margin is 23811.29% (2021), against an average of 27601.94%.
- Across the five-year window, FCF Margin plunged 8014194 bps in 2021 and jumped 7410968 bps in 2022, its largest moves.
- Candel Therapeutics' FCF Margin stood at 15558.06% in 2020, then plunged by 515 bps to 95700.0% in 2021, then jumped by 77 bps to 21590.32% in 2022.
- The last three FCF Margin figures came in at 21590.32% (Q4 2022), 28512.9% (Q3 2022), and 24135.48% (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Candel Therapeutics | 440.62 Mn | 440.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -21,590.32% |
| Sep 30, 2022 | -28,512.90% |
| Jun 30, 2022 | -24,135.48% |
| Mar 31, 2022 | -27,335.48% |
| Dec 31, 2021 | -95,700.00% |
| Sep 30, 2021 | -23,503.23% |
| Jun 30, 2021 | -11,445.16% |
| Mar 31, 2021 | -24,119.35% |
| Dec 31, 2020 | -15,558.06% |
| Sep 30, 2020 | -4,119.35% |